RGT-61159
RGT-61159 Phase 1a/b
Rgenta Therapeutics · Phase 1 · Active, not recruiting · Enrollment 105
| Arm | Reported safety |
|---|---|
| RGT-61159 at or below RP2D | n/r |
A count stays a count. This page does not turn a count into a percent.
ACC
Programs, trials, and reported response and survival for adenoid cystic carcinoma.
RGT-61159
Rgenta Therapeutics · Phase 1 · Active, not recruiting · Enrollment 105
| Arm | Reported safety |
|---|---|
| RGT-61159 at or below RP2D | n/r |
A count stays a count. This page does not turn a count into a percent.